Page 19 - Axonics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Axonics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Axonics Today - Breaking & Trending Today
CL King started coverage on shares of Axonics (NASDAQ:AXNX – Get Rating) in a report released on Tuesday, The Fly reports. The brokerage set a “buy” rating and a $75.00 price target on the stock. CL King’s price objective indicates a potential upside of 46.51% from the company’s current price. A number of other analysts […] ....
Shares of Axonics, Inc. (NASDAQ:AXNX – Get Rating) have earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among brokers […] ....
Sectoral Asset Management Inc. lessened its holdings in Axonics, Inc. (NASDAQ:AXNX – Get Rating) by 23.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 87,646 shares of the company’s stock after selling 26,650 shares during the quarter. Sectoral […] ....
How dupixent can help heal their skin from within. if you re still having bladder leaks, it s time for a change. axonics therapy gave me my life back. it s not another pad or pill. it s amazing that a tiny device can provide 15 years of relief - and you can try it out first. get started at findrealrelief.com ask a bladder specialist if axonics therapy is right for you and to discuss potential risks. results and experiences may vary. let s get your life back! [bones cracking] (tense music) one aleve works all day so i can keep working my magic. just one aleve. ....
Jennison Associates LLC lessened its holdings in shares of Axonics, Inc. (NASDAQ:AXNX – Get Rating) by 39.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 200,083 shares of the company’s stock after selling 128,460 shares during the quarter. Jennison […] ....